The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index; 78 of the 198 sources its claims cite were checked for support.
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Open accessAbstract
Cancer is the leading cause of death worldwide. The complex and disorganized tumor microenvironment makes it very difficult to treat this disease. The most common in vitro drug screening method now is based on 2D culture models which poorly represent actual tumors. Therefore, many 3D tumor models which are more physiologically relevant have been developed to conduct in vitro drug screening and alleviate this situation. Among all these models, the microfluidic tumor model has the unique advantage of recapitulating the tumor microenvironment in a comparatively easier and representative fashion. While there are many review papers available on the related topic of microfluidic tumor models, in this review we aim to focus more on the possibility of generating "clinically actionable information" from these microfluidic systems, besides scientific insight. Our topics cover the tumor microenvironment, conventional 2D and 3D cultures, animal models, and microfluidic tumor models, emphasizing their link to anti-cancer drug discovery and personalized medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
78 of 198 cited sources checked · 24 supported · 4 flagged · accuracy not yet measured
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Through this, it was shown that adenosine played an important role in promoting tumor cells extravasation.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Disputedcites [98] 98. Jeon, J.S., et al., Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proceedings of the National Academy of Sciences, 2015. 112(1): p. 214-219. sourceExperimental — accuracy not yet measured
The Results (p. 5) report that adding adenosine significantly reduced cancer cell extravasation, from 56.5% to 12.7%, rather than promoting it. The Fig. 3 caption (p. 6) confirms that extravasation decreased with adenosine. (LLM, conf=0.94)
Checked by a reasoning model — may be wrong.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“By blocking A3 adenosine receptors, cancer cells were observed to have a reduced extravasation rate.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Disputedcites [98] 98. Jeon, J.S., et al., Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proceedings of the National Academy of Sciences, 2015. 112(1): p. 214-219. sourceExperimental — accuracy not yet measured
The Results (p. 5) report the opposite effect: blocking A3 adenosine receptors with PSB-10 significantly increased cancer cell extravasation in C2C12-containing matrices, from 8.2 ± 2.3% to 32.4 ± 7.7%. The Fig. 3 caption (p. 6) also states that extravasation increased with receptor blockade. (LLM, conf=0.95)
Checked by a reasoning model — may be wrong.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“The uniformly elevated IFP in tumor center is responsible for inhibiting drug delivery [172, 178, 186] while the steep pressure gradients at the periphery favors tumor growth and metastasis[154,[187][188][189][190].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Disputedcites [154] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) links elevated tumor pressure to outward interstitial flow, but does not identify steep gradients at the tumor periphery or show that they favor growth. More importantly, the Results and Discussion (page unavailable) report that, despite increasing cell speed, flow impaired the cells’ ability to spread to a distant site—the opposite of the claimed effect on metastasis. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [187] sourceExperimental — accuracy not yet measured
The Introduction says pressure falls sharply at the tumor margin, creating fluid flow that transports molecules and cells facilitating angiogenesis and metastasis. The Mathematical model section says less steep gradients could potentially reduce lymphatic metastasis. The paper does not explicitly link the peripheral gradient to tumor growth, and presents its effect on metastasis as a proposed mechanism rather than an established outcome. (LLM, conf=0.84)
- Partly supportedcites [188] sourceExperimental — accuracy not yet measured
The Introduction says interstitial fluid pressure may stretch the tumor cortex and thereby promote proliferation; the Discussion reports that lowering pressure reduced proliferation in a xenograft model. The Discussion also describes pressure falling from the tumor core toward the cortex. Neither passage establishes that steep peripheral pressure gradients favor metastasis, and the growth finding concerns pressure-induced stretch rather than the gradient itself. Page numbers are unavailable in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [189] source
- Partly supportedcites [190] sourceExperimental — accuracy not yet measured
The Results and the discussion on p. 2395 report that elevated pressure affected osteosarcoma-cell proliferation, with growth increasing in some cell lines and being suppressed in others. The paper does not show that steep pressure gradients at the tumor periphery favor growth, and it does not link those gradients to metastasis. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Over the years, research has demonstrated that the tumor microenvironment plays a key role in this process [3,6,7].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [3] 3. Hanahan, D. and R.A. Weinberg, Hallmarks of cancer: The next generation. Cell, 2011. 144(5): p. 646-674. source
- Not checked — no full text of the sourcecites [6] 6. Kessenbrock, K., V. Plaks, and Z. Werb, Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell, 2010. 141(1): p. 52-67. source
- Supportedcites [7] 7. Mantovani, A., et al., Cancer-related inflammation. Nature, 2008. 454(7203): p. 436-444. source
The opening section (p. 1) states that inflammation in the tumour microenvironment promotes metastasis. The section on invasion and metastasis (p. 5) further describes how inflammatory cells and mediators contribute to malignant-cell migration, invasion and metastasis. (LLM, conf=0.93)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the former, due to the physical contact between cells, this allows for the study of adhesion molecules such as Ncadherins [50].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
What the sources say
- Partly supportedcites [50] 50. De Wever, O. and M. Mareel, Role of tissue stroma in cancer cell invasion. The Journal of Pathology, 2003. 200(4): p. 429-447. sourceExperimental — accuracy not yet measured
The sections “The normal epithelial ecosystem” and “The cancer ecosystem” describe co-culture systems and direct cell–cell contacts. “Molecular mechanisms of N-cadherin-mediated invasion and migration” links N-cadherin to cell–cell contact, but the paper does not say that direct co-culture is used to study adhesion molecules such as N-cadherin. (LLM, conf=0.83)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The ECM is known to influence cell behavior in terms of cell migration, and anchorage, by serving as a medium to transmit external forces from environmental cues and even cell signaling throughout the entire lifespan of the cell and at critical phases in their lives [19,20].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
What the sources say
- Supportedcites [19] 19. Hynes, R.O., The Extracellular Matrix: Not Just Pretty Fibrils. Science, 2009. 326(5957): p. 1216-1219. source
The Introduction says the ECM provides substrates for cell motility, supports cell adhesion, and signals to cells through adhesion receptors. It also says matrix stiffness and deformability provide inputs into cell behavior, and that cells contact the ECM either continuously or at important developmental phases. (LLM, conf=0.91)
- Supportedcites [20] 20. Lu, P., V.M. Weaver, and Z. Werb, The extracellular matrix: A dynamic niche in cancer progression. Journal of Cell Biology, 2012. 196(4): p. 395-406. source
The “Properties and features of the ECM” section (page not provided) describes the ECM as an anchorage site or movement track that affects cell migration. It also explains how ECM elasticity shapes cells’ responses to external forces and how the ECM regulates signaling and cell behavior. (LLM, conf=0.90)
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, by studying the genetic alterations in the tumor cells, the events through which the stroma affects cancer cells can be elucidated [48].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
What the sources say
- Partly supportedcites [48] 48. Mao, Y., et al., Stromal cells in tumor microenvironment and breast cancer. Cancer and Metastasis Reviews, 2013. 32(1-2): p. 303-315. sourceExperimental — accuracy not yet measured
The Abstract says that the molecular events through which reactive stromal cells affect cancer cells can be defined. Section 2.5 discusses genetic changes within tumor cells, but does not say that studying those changes is how stromal effects can be elucidated. The cited paper therefore supports the outcome, not the proposed method. (LLM, conf=0.87)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the latter, signaling pathways between the different types of cells such as cancer cells and fibroblasts can be better studied [51].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
What the sources say
- Partly supportedcites [51] 51. Casbas-Hernandez, P., J.M. Fleming, and M.A. Troester, Gene Expression Analysis of In Vitro Cocultures to Study Interactions between Breast Epithelium and Stroma. Journal of Biomedicine and Biotechnology, 2011. 2011: p. 1-12. sourceExperimental — accuracy not yet measured
Section 2.1 describes indirect transwell cocultures used to examine gene-expression responses between breast cancer cells and fibroblasts, including changes in a signaling pathway. It does not establish that signaling pathways are generally better studied in indirect than in direct coculture; it notes that direct contact can produce distinct profiles, although separating the cells requires additional steps. Page numbers were not provided in our copy. (LLM, conf=0.78)
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As a tumor will be cultivated in vivo within these animals, it is also able to better mimic the molecular and histopathological features of cancer [40,41].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
What the sources say
- Partly supportedcites [40] 40. Kersten, K., et al., Genetically engineered mouse models in oncology research and cancer medicine. EMBO Molecular Medicine, 2017. 9(2): p. 137-153. sourceExperimental — accuracy not yet measured
The Abstract (p. 1) says tumors arising in advanced genetically engineered mouse models closely mimic the histopathological and molecular features of human cancers. The claim extends that finding to tumors cultivated in vivo in animals generally, but the Xenotransplantation section (p. 3) says in vivo cell-line inoculation models do not reflect the morphology and genetic heterogeneity of human cancers. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [41] 41. Singh, M., C.L. Murriel, and L. Johnson, Genetically engineered mouse models: Closing the gap between preclinical data and trial outcomes. Cancer Research, 2012. 72(11): p. 2695- 2700. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Conversely, the reproducibility of a tumor also becomes an issue since a tumor is highly heterogeneous and varies not only between patients but also between different tumors or even within the same tumor inside an individual patient [38].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
What the sources say
- Partly supportedcites [38] 38. Swanton, C., Intratumor Heterogeneity: Evolution through Space and Time. Cancer Research, 2012. 72(19): p. 4875-4882. sourceExperimental — accuracy not yet measured
The Abstract describes heterogeneity between tumours and within individual tumours, and “Clinical Implications of ITH > A. Tumour Sampling Bias” explains how variation between sampled sites can complicate biomarker validation. The paper does not specifically address the reproducibility of tumour explants, so that application goes beyond what our copy establishes. (LLM, conf=0.83)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The overexpression of these collagens leads to the formation of a stiffer ECM which in turn promotes the formation of a tumorigenic microenvironment [26].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
What the sources say
- Supportedcites [26] 26. Fang, M., et al., Collagen as a double-edged sword in tumor progression. Tumour Biology, 2014. 35(4): p. 2871-2882. source
The 'Increased deposition and cross-linking of collagens' section says increased collagen deposition and ECM remodeling create a microenvironment that promotes tumor progression. The 'Tension homeostasis and tumor progression' section says ECM protein deposition and matrix cross-linking can stiffen tissue. Together, these support the paraphrased claim; page numbers were not available in our copy. (LLM, conf=0.88)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Such heterogeneity is observed in the cohort of circulating tumor cells (CTCs) [12,13], which can be isolated from the peripheral bloodstream or cultured for further analyses.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 1. Introduction
What the sources say
- Supportedcites [12] 12. Khoo, B.L., et al., Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment. Science Advances, 2016. 2(e1600274). source
The Discussion explicitly refers to “heterogeneous CTCs” and explains that detection markers do not apply to all CTC subpopulations. It also describes differences in their epithelial and mesenchymal characteristics, supporting the claim that CTCs are heterogeneous. (LLM, conf=0.94)
- Supportedcites [13] 13. Zhang, L., et al., The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med, 2013. 5(180): p. 180ra48. source
The Discussion explicitly states that CTCs are a heterogeneous population (passage 4). The Methods describe collecting peripheral blood for CTC analysis (passage 8), and the Results describe generating and culturing CTC lines (passages 5–6). (LLM, conf=0.94)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“It was shown that human non-small cell lung cancer cells (PC9) cultured in their devices had stronger drug resistance to four different apoptotic inducers than two-dimensional cultured PC9 cells.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Supportedcites [81] 81. Dereli-Korkut, Z., et al., Three dimensional microfluidic cell arrays for ex vivo drug screening with mimicked vascular flow. Analytical Chemistry, 2014. 86(6): p. 2997-3004. source
The Experimental Section identifies four apoptotic inducers tested on PC9 cells in conventional dishes and the 3D device. The Discussion reports that static 3D PC9/HMVEC cocultures responded similarly to 2D monolayers, while responses in the device were reduced and delayed relative to static cocultures. This supports stronger drug resistance in the device, as measured by reduced caspase-3 response. (LLM, conf=0.85)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, 2D cultured cells are artificially polarized when their cytoskeleton rearranges as they are stretched on the culture plate, which in turn causes these cultured cells to express genes and proteins which are atypical [56].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
What the sources say
- Supportedcites [56] 56. Nath, S. and G.R. Devi, Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. Pharmacology and Therapeutics, 2016. 163: p. 94-108. source
The Introduction directly states that 2D-cultured cells are stretched, undergo cytoskeletal rearrangements, acquire artificial polarity, and consequently show aberrant gene and protein expression. This supports the citing sentence’s paraphrase. (LLM, conf=0.94)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Specifically, the location of focal adhesions and the various cell surface proteins such as integrin and their binding has been demonstrated to be markedly different from their original 3D form [54,55].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
What the sources say
- Not checked — no full text of the sourcecites [54] 54. Cukierman, E., et al., Taking Cell-Matrix Adhesions to the Third Dimension. Science, 2001. 294(5547): p. 1708-1712. source
- Partly supportedcites [55] 55. Gumbiner, B.M., Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell, 1996. 84(3): p. 345-357. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says that focal adhesions contain integrins and that ligand binding controls integrin localization within them. It does not demonstrate that focal adhesion locations, cell-surface proteins, or their binding differ markedly from an original 3D form. (LLM, conf=0.82)
Load-bearingStrength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“In recent years, techniques which can overcome the abnormal vasculature in the tumor, such as nanoparticle drug delivery and drugs normalizing vascular network, were shown to be able to greatly improve anti-cancer treatment [108-113].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [108] 108. Trietsch, S.J., et al., Microfluidic titer plate for stratified 3D cell culture. Lab on a Chip, 2013. 13(18): p. 3548-3554. 132. Napolitano, A., et al., Scaffold-free three-dimensional cell culture utilizing micromolded nonadhesive hydrogels. BioTechniques, 2007. 43(4): p. 494-500. 133. Xu, Z., et al., Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials, 2013. 34(16): p. 4109-17. 134. Zhang, Z., et al., Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotar source
- Not checked — no full text of the sourcecites [109] 109. Choi, Y., et al., A microengineered pathophysiological model of early-stage breast cancer. Lab on a Chip, 2015. 15(16): p. 3350-7. 137. Ke, L.-Y., et al., Cancer immunotherapy μ-environment LabChip: taking advantage of optoelectronic tweezers. Lab on a Chip, 2018. 18(1): p. 106-114. 138. Huh, D., et al., A human disease model of drug toxicity-induced pulmonary edema in a lung- on-a-chip microdevice. Science translational medicine, 2012. 4(159): p. 159ra147-159ra147. 139. source
- Not checked — no full text of the sourcecites [110] 110. Bender, B.F., A.P. Aijian, and R.L. Garrell, Digital microfluidics for spheroid-based invasion assays. Lab on a Chip, 2016. 16(8): p. 1505-13. 140. Shin, Y., et al., Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels. Nature protocols, 2012. 7(7): p. 1247-59. 141. Kim, J.Y., et al., 3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis. Journal of biotechnology, 2015. 205: p. 24-35. 142. Menon, N.V., et al., A microfluidic co-culture system to monitor tumor-stromal interactions on a chip. Biomicroflu source
- Not checked — no full text of the sourcecites [111] 111. Avvisato, C.L., et al., Mechanical force modulates global gene expression and β-catenin signaling in colon cancer cells. J Cell Sci, 2007. 120(15): p. 2672-2682. 151. Swartz, M.A. and A.W. Lund, Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nature reviews. Cancer, 2012. 12(3): p. 210-9. 152. source
- Not checked — no full text of the sourcecites [112] 112. Song, J.W. and L.L. Munn, Fluid forces control endothelial sprouting. Proceedings of the National Academy of Sciences, 2011. 108(37): p. 15342-15347. 153 source
- Could not verifycites [113] 113. Fan, R., et al., Circulatory shear flow alters the viability and proliferation of circulating colon cancer cells. Scientific reports, 2016. 6: p. 27073. 154. Huang, Y.L., et al., Interstitial flows promote amoeboid over mesenchymal motility of breast cancer cells revealed by a three dimensional microfluidic model. Integrative Biology, 2015. sourceExperimental — accuracy not yet measured
The Abstract and Discussion describe how circulatory shear stress affects colon cancer cell viability and proliferation, not treatments that overcome abnormal tumor vasculature. Searches for nanoparticle drug delivery and vascular normalization found no passage addressing whether those techniques improve anti-cancer treatment; no page numbers are available in our copy. (LLM, conf=0.75)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The blood circulation system is also a key component in metastasis because many malignant cells migrate as circulating cancer cells through blood vessels [105].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Could not verifycites [105] 105. Easwaran, H., H.-C. Tsai, and S.B. Baylin, Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Molecular cell, 2014. 54(5): p. 716-727. 121. sourceExperimental — accuracy not yet measured
The sections on tumor heterogeneity discuss differences between primary tumors and metastases, and the section on epigenetic alterations mentions migratory capabilities. Neither addresses whether malignant cells travel through blood vessels as circulating cancer cells or establishes the blood circulation system’s role in metastasis. Searches for circulating tumor cells, blood vessels, bloodstream, and vascular dissemination found no supporting passage. (LLM, conf=0.76)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [103] 103. Sun, T., et al., Engineered nanoparticles for drug delivery in cancer therapy. Angewandte Chemie International Edition, 2014. 53(46): p. 12320-12364. 113. source
- Not checked — no full text of the sourcecites [114] 114. 11): p. 1402-1411. 155. Astolfi, M., et al., Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy. Lab on a Chip, 2016. 16(2): p. 312-325. 156. source
- Could not verifycites [115] 115. Ip, C.K., et al., Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress. Scientific reports, 2016. 6: p. 26788. 157. sourceExperimental — accuracy not yet measured
The Abstract and Discussion address chemoresistance in ovarian cancer cells under fluid shear stress, not the cellular composition of most cancers. Searches for endothelial cells, fibroblasts, immune cells, and stromal cell types found no passage identifying them as the three main non-neoplastic cell types. (LLM, conf=0.76)
- Partly supportedcites [116] 116. Alonzo, L.F., et al., Microfluidic device to control interstitial flow-mediated homotypic and heterotypic cellular communication. Lab on a Chip, 2015. 15(17): p. 3521-9. 158. Oh, J., et al., Analytical cell adhesion chromatography reveals impaired persistence of metastatic cell rolling adhesion to P-selectin. Journal of cell science, 2015. 128(20): p. 3731- 43. 159. Calibasi Kocal, G., et al., Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow. Scientific reports, 2016. 6: p. 38221. 160. Kang, T., C. Park, and B.J. Lee, Investigation of biomimetic sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) identifies fibroblasts and infiltrating immune cells as surrounding non-tumor cells involved in tumor progression. The paper also studies endothelial cells and fibroblasts, but it does not say these three are the main non-neoplastic cell types in most cancers or establish the citing sentence’s drug-resistance claim. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [117] 117. Trietsch, S.J., et al., Microfluidic titer plate for stratified 3D cell culture. Lab on a Chip, 2013. 13(18): p. 3548-54. 163. Khoo, B.L., et al., Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device. Nat Protoc, 2018. 13(1): p. 34-58. 164. Businaro, L., et al., Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment. Lab on a Chip, 2013. 13(2): p. 229-239. 165. Holton, A.B., et al., Microfluidic Biopsy Trapping Device for the Real-Time Monitoring of Tumor Microenvironment. PLoS One, source
- Not checked — no full text of the sourcecites [118] 118. Douville, N.J., et al., Combination of fluid and solid mechanical stresses contribute to cell death and detachment in a microfluidic alveolar model. Lab on a Chip, 2011. 11(4): p. 609- 19. 167. Piotrowski-Daspit, A.S., J. Tien, and C.M. Nelson, Interstitial fluid pressure regulates collective invasion in engineered human breast tumors via Snail, vimentin, and E-cadherin. Integrative biology : quantitative biosciences from nano to macro, 2016. 8(3): p. 319-31. 168. Polacheck, W.J., et al., Mechanotransduction of fluid stresses governs 3D cell migration. Proceedings of the National Academy source
- Not matchedcites [119] 119. Less, J.R., et al., Interstitial hypertension in human breast and colorectal tumors. Cancer research, 1992. 52(22): p. 6371-6374. 173. Curti, B.D., et al., Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. Cancer research, 1993. 53(10): p. 2204-2207. 174. Gutmann, R., et al., Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer research, 1992. 52(7): p. 1993-1995. 175. Griffon-Etienne, G., et al., Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [120] 120. Wilson, W.R. and M.P. Hay, Targeting hypoxia in cancer therapy. Nature Reviews Cancer, 2011. 11(6): p. 393. 184. Carmeliet, P. and R.K. Jain, Molecular mechanisms and clinical applications of angiogenesis. Nature, 2011. 473(7347): p. 298-307. 185. source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesEvery source the paper cites for this claim was checked and supports it.
In the paper
“By using this microfluidic device, it was shown that CAFs might promote NSCLC cell invasion by up-regulation of GRP78 expression.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Supportedcites [143] source
The Abstract explicitly concludes that CAFs might promote NSCLC cell invasion by up-regulating GRP78 expression. The Results sections report that CAF-conditioned medium increased GRP78 expression in A549 and SPCA-1 cells and that GRP78 knockdown reduced their migration and invasion in the microdevice. (LLM, conf=0.95)
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Formation of cell clusters in the microwells was shown to be inversely correlated with increased drug concentration and therapeutic treatment and this liquid biopsy technique can potentially be used to develop personalized medicine.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Supportedcites [135] source
The Results report that the percentage of microwells with clusters decreased as doxorubicin concentration increased, and that CTC-containing cluster formation appeared to correlate negatively with patient response. The Discussion also reports fewer positive cluster cultures in posttreatment than pretreatment samples (19.6% versus 59.3%). (LLM, conf=0.91)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Immune cells were shown to both enhance and inhibit malignant cells proliferation, migration, and metastasis [125-128].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [125] 125. Weigelt, B., J.L. Peterse, and L.J. Van't Veer, Breast cancer metastasis: markers and models. Nature reviews cancer, 2005. 5(8): p. 591. 197. Muz, B., et al., The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia, 2015. 3: p. 83. 198. source
- Not checked — no full text of the sourcecites [126] 126. Kamei, K.-i., et al., 3D printing of soft lithography mold for rapid production of polydimethylsiloxane-based microfluidic devices for cell stimulation with concentration gradients. Biomedical microdevices, 2015. 17(2): p. 36. 199. source
- Could not verifycites [127] 127. Uzel, S.G., et al., Simultaneous or Sequential Orthogonal Gradient Formation in a 3D Cell Culture Microfluidic Platform. Small, 2016. 12(5): p. 612-22. 200. sourceExperimental — accuracy not yet measured
Section 2.3 discusses cancer-cell migration in the metastatic cascade and responses to chemical gradients, but does not address immune cells enhancing or inhibiting malignant-cell proliferation, migration, or metastasis. Searches for immune-cell effects and tumor proliferation found no passage supporting the attributed point; no page number was provided in our copy. (LLM, conf=0.76)
- Not matchedcites [128] 128. Al-Abboodi, A., et al., In situ generation of tunable porosity gradients in hydrogel-based scaffolds for microfluidic cell culture. Adv Healthc Mater, 2014. 3(10): p. 1655-70. 201. Del Amo, C., et al., Quantifying 3D chemotaxis in microfluidic-based chips with step gradients of collagen hydrogel concentrations. Integr Biol (Camb), 2017. 9(4): p. 339-349. 202. Zou, H., et al., Microfluidic Platform for Studying Chemotaxis of Adhesive Cells Revealed a Gradient-Dependent Migration and Acceleration of Cancer Stem Cells. Anal Chem, 2015. 87(14): p. 7098-108. 203. Wang, H., et al., A convection
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesEvery source the paper cites for this claim was checked and supports it.
In the paper
“Formation of cell clusters in the microwells was shown to be inversely correlated with increased drug concentration and therapeutic treatment and this liquid biopsy technique can potentially be used to develop personalized medicine.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Supportedcites [135] source
The Discussion describes the microwell-based liquid-biopsy assay as a potential way to assess drug response and guide therapeutic choices for personalized treatment. It also says routine assessment of serial clinical samples could eventually enable personalized treatment. Page numbers were not provided in the supplied passages. (LLM, conf=0.93)
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [103] 103. Sun, T., et al., Engineered nanoparticles for drug delivery in cancer therapy. Angewandte Chemie International Edition, 2014. 53(46): p. 12320-12364. 113. source
- Not checked — no full text of the sourcecites [114] 114. 11): p. 1402-1411. 155. Astolfi, M., et al., Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy. Lab on a Chip, 2016. 16(2): p. 312-325. 156. source
- Could not verifycites [115] 115. Ip, C.K., et al., Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress. Scientific reports, 2016. 6: p. 26788. 157. sourceExperimental — accuracy not yet measured
The Results and Discussion passages attribute increased chemoresistance in ovarian cancer spheroids to fluid shear stress, not to endothelial cells, fibroblasts, or immune cells. Searches for those three cell types and for stromal cells enhancing chemoresistance found no passage in our copy supporting the attributed claim; page numbers were unavailable. (LLM, conf=0.76)
- Could not verifycites [116] 116. Alonzo, L.F., et al., Microfluidic device to control interstitial flow-mediated homotypic and heterotypic cellular communication. Lab on a Chip, 2015. 15(17): p. 3521-9. 158. Oh, J., et al., Analytical cell adhesion chromatography reveals impaired persistence of metastatic cell rolling adhesion to P-selectin. Journal of cell science, 2015. 128(20): p. 3731- 43. 159. Calibasi Kocal, G., et al., Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow. Scientific reports, 2016. 6: p. 38221. 160. Kang, T., C. Park, and B.J. Lee, Investigation of biomimetic sourceExperimental — accuracy not yet measured
The Introduction links fibroblasts and infiltrating immune cells to tumor progression, and the Discussion describes endothelial-cell vessel formation. Neither passage addresses whether these three cell types enhance tumor drug resistance; searches for drug resistance and treatment found no such passage in our copy. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [117] 117. Trietsch, S.J., et al., Microfluidic titer plate for stratified 3D cell culture. Lab on a Chip, 2013. 13(18): p. 3548-54. 163. Khoo, B.L., et al., Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device. Nat Protoc, 2018. 13(1): p. 34-58. 164. Businaro, L., et al., Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment. Lab on a Chip, 2013. 13(2): p. 229-239. 165. Holton, A.B., et al., Microfluidic Biopsy Trapping Device for the Real-Time Monitoring of Tumor Microenvironment. PLoS One, source
- Not checked — no full text of the sourcecites [118] 118. Douville, N.J., et al., Combination of fluid and solid mechanical stresses contribute to cell death and detachment in a microfluidic alveolar model. Lab on a Chip, 2011. 11(4): p. 609- 19. 167. Piotrowski-Daspit, A.S., J. Tien, and C.M. Nelson, Interstitial fluid pressure regulates collective invasion in engineered human breast tumors via Snail, vimentin, and E-cadherin. Integrative biology : quantitative biosciences from nano to macro, 2016. 8(3): p. 319-31. 168. Polacheck, W.J., et al., Mechanotransduction of fluid stresses governs 3D cell migration. Proceedings of the National Academy source
- Not matchedcites [119] 119. Less, J.R., et al., Interstitial hypertension in human breast and colorectal tumors. Cancer research, 1992. 52(22): p. 6371-6374. 173. Curti, B.D., et al., Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. Cancer research, 1993. 53(10): p. 2204-2207. 174. Gutmann, R., et al., Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer research, 1992. 52(7): p. 1993-1995. 175. Griffon-Etienne, G., et al., Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [120] 120. Wilson, W.R. and M.P. Hay, Targeting hypoxia in cancer therapy. Nature Reviews Cancer, 2011. 11(6): p. 393. 184. Carmeliet, P. and R.K. Jain, Molecular mechanisms and clinical applications of angiogenesis. Nature, 2011. 473(7347): p. 298-307. 185. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Due to the presence of interstitial flow in tumors, there is a corresponding fluid shear stress with a magnitude of approximately 0.1 dyn 𝑐𝑚 -2 [149].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Partly supportedcites [149] sourceExperimental — accuracy not yet measured
The ‘Fluid Shear Stress Exposure in the Tumor Microenvironment’ section says interstitial flow generates cell-surface shear stress believed to be on the order of 0.1 dyn cm−2. It does not establish that magnitude specifically for tumors; the same section says interstitial flows can be significantly elevated in tumors. Page numbers are unavailable in our copy. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“They demonstrated the change in 88 metabolites during cellular adaptation to hypoxia gradient and found that cell metabolism was deregulated in the absence of HIF.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
What the sources say
- Partly supportedcites [216] sourceExperimental — accuracy not yet measured
The 'Metabolomic signature mapping in 3D' section says 88 metabolites were analyzed, but only 23 showed a significant correlation with hypoxia in control cells; it does not report changes in all 88. The 'HIF-dependent and HIF-independent metabolic signatures' section reports changes in several metabolites in HIF-knockdown cells, but the Outlook says changes in glycolysis and mitochondrial metabolism were largely HIF-independent. Thus the broad statement that cell metabolism was deregulated in the absence of HIF overstates the findings. (LLM, conf=0.88)
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Different from these engineering approaches, some recent works adopted 3D tissue structures to reconstitute the oxygen gradient in the tumor [215, 216].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
What the sources say
- Supportedcites [215] source
The paper describes its use of 3D tumor spheroids and states that spheroids have oxygen gradients along their radius, mimicking an avascular solid tumor (Introduction passage supplied under Abstract). The Discussion also says oxygen tension is lower within a spheroid because diffusion is limited and cells consume oxygen. (LLM, conf=0.90)
- Supportedcites [216] source
The Abstract describes a three-dimensional tumour model assembled by rolling a scaffold–tumour strip and says that oxygen gradients form within it. The section ‘Oxygen gradient dynamics reveal HIF-dependent adaptations’ states that the model establishes oxygen gradients from normoxia to severe hypoxia, as observed in tumours. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“By observing cell behavior in these devices, it was found that different types of cancer cells may react differently to the same chemical stimuli.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
What the sources say
- Not checked — no full text of the sourcecites [198] source
- Partly supportedcites [199] sourceExperimental — accuracy not yet measured
Section 2.3 reports that HT1080 cancer cells responded to a chemical gradient, supporting the claim that cancer cells can react to chemical stimuli. It does not show different cancer cell types responding differently to the same stimulus: its comparison with MDA-MB-231 cells concerns interstitial flow, a different cue. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [200] source
- Not checked — no full text of the sourcecites [201] source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe cited sources support only part of this claim — read each source’s verdict below.
In the paper
“They rebuilt largely in vitro 3D tumor tissues and were able to generate a hypoxic environment in the inner core, which greatly recapitulated in vivo spatial oxygen distribution.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
What the sources say
- Partly supportedcites [215] sourceExperimental — accuracy not yet measured
The introduction describes oxygen gradients across spheroids that mimic avascular tumors, and the Discussion says limited oxygen diffusion can create a hypoxic core similar to that of solid tumors. The paper does not establish the oxygen distribution in its own HepG2 spheroids, so the claim that these particular structures generated a hypoxic core and closely reproduced the in vivo distribution goes beyond its findings. (LLM, conf=0.82)
- Supportedcites [216] source
The Abstract describes an engineered 3D tumour assembled by rolling a scaffold–tumour strip and says its oxygen gradients and responses are consistent with tumours in vivo. In “Oxygen gradient dynamics reveal HIF-dependent adaptations,” the authors report an outer-to-inner oxygen gradient and severe hypoxia in the deep layers. (LLM, conf=0.94)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Current microfluidic tumor models with mimicked vasculature have demonstrated that tumor cells exhibit increased drug resistance when artificial blood vessels were used [81].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
What the sources say
- Partly supportedcites [81] 81. Dereli-Korkut, Z., et al., Three dimensional microfluidic cell arrays for ex vivo drug screening with mimicked vascular flow. Analytical Chemistry, 2014. 86(6): p. 2997-3004. sourceExperimental — accuracy not yet measured
The Results (Profiles of Caspase-3 Activity in Different Culture Configurations; page unavailable) report slower and lower maximum drug responses in PC9 lung cancer cells cultured with mimicked microvessels than in static 3D coculture. This supports reduced drug response in that comparison, but the broader claim of increased tumor-cell drug resistance overstates the finding: the authors measured apoptotic response and only speculate that the endothelial layer delayed drug delivery. (LLM, conf=0.84)
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Most research is focused on how IFP prompts cancer cells migration and metastasis [157,[167][168][169].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Could not verifycites [157] sourceExperimental — accuracy not yet measured
The Introduction says interstitial flow can affect cellular behavior and that tumor progression depends on interactions with surrounding cells. It does not say that most research focuses on IFP-induced cancer-cell migration or metastasis. Searches for those topics found no passage making that claim. (LLM, conf=0.74)
- Partly supportedcites [167] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) describes several studies of how IFP and interstitial flow affect cancer-cell migration, and the paper investigates migration and invasion. The Discussion (page unavailable) mentions metastasis only as a potential consequence; it does not establish that most research focuses on migration and metastasis or that IFP prompts metastasis. (LLM, conf=0.83)
- Partly supportedcites [168] sourceExperimental — accuracy not yet measured
The introduction (p. 2) says elevated interstitial fluid pressure drives interstitial flow that influences tumor-cell migration. The Discussion (p. 6) links this mechanism to metastasis as a possible implication, but does not demonstrate that it causes metastasis or establish that most research focuses on this question. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [169] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Human endothelial cells can sprout in hydrogels to develop a vascular network with dimensions similar to real capillaries [96,107].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
What the sources say
- Not checked — no full text of the sourcecites [96] 96. Ahn, J., et al., Probing the effect of bioinspired nanomaterials on angiogenic sprouting using a microengineered vascular system. IEEE Transactions on Nanotechnology, 2017: p. 1-1. source
- Could not verifycites [107] 107. Vu, T.Q., R.M.B. de Castro, and L. Qin, Bridging the gap: microfluidic devices for short and long distance cell-cell communication. Lab on a Chip, 2017. 17(6): p. 1009-1023. 130. Benam, K.H., et al., Engineered in vitro disease models. Annual Review of Pathology: Mechanisms of Disease, 2015. 10: p. 195-262. 131. sourceExperimental — accuracy not yet measured
The Long Distance Communication section mentions hydrogels as a way to separate cells while allowing signaling proteins to pass between them. The Wound Healing section discusses endothelial-cell migration, but neither section describes human endothelial cells sprouting in hydrogels or forming networks with capillary-like dimensions (searched: sprouting, vascular network, capillaries). (LLM, conf=0.76)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The uniformly elevated IFP in tumor center is responsible for inhibiting drug delivery [172, 178, 186] while the steep pressure gradients at the periphery favors tumor growth and metastasis[154,[187][188][189][190].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Not checked — no full text of the sourcecites [172]
- Not matchedcites [178]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites [186] source
The paper’s discussion of its model (section labelled Abstract; page not provided) reports elevated IFP in the tumour centre with no transvascular pressure difference. It also states that elevated IFP hinders drug delivery by eliminating the pressure gradients needed for convective penetration. (LLM, conf=0.91)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Due to the direct use of tumor tissue, this approach includes many key components in tumor such as heterogeneous cell types and abnormal blood vessel networks.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
What the sources say
- Not checked — no full text of the sourcecites [155] source
- Partly supportedcites [165] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says the biopsy-based approach maintains interactions between tumor tissue and its microenvironment in their biological configuration, and describes tumors as heterogeneous tissue involving multiple cell types. The paper does not say that the cultured biopsies include abnormal blood-vessel networks; its references to vascular capillaries and endothelial cells do not establish that point. (LLM, conf=0.87)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, the various types of cells in tumor tissues were all treated as tumor cells in these studies.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
What the sources say
- Not checked — no full text of the sourcecites [155] source
- Partly supportedcites [165] sourceExperimental — accuracy not yet measured
The Materials and Methods section (‘Measurement of viability and death’; page unavailable) calculates viability from fluorescence across whole tumor fragments, without describing a separation of cancer cells from other cell types. The Discussion distinguishes cancer cells from stromal components, however, and the paper does not say that every cell type was treated as a tumor cell. The claim is supported as a description of aggregate measurement, but not as a literal classification of all cells. (LLM, conf=0.78)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Although many in vitro microvessel models have been developed, none of them can actually reproduce the architecture of capillaries seen in a tumor [217,218].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
What the sources say
- Could not verifycites [217] sourceExperimental — accuracy not yet measured
The Capillaries section describes how tumour-associated capillaries form through intraluminal bridging, but does not compare their architecture with in vitro models. Searches for in vitro microvessel models and their ability to reproduce tumour vessels found no passage addressing the claim. (LLM, conf=0.74)
- Not checked — no full text of the sourcecites [218] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Could not verify
In the paper
“Even though a tumor is essentially being cultivated in a surrogate human model, this method has demonstrated some success over the years such as the discovery of APC gene suppression which initiates tumor formation in an animal mouse model of human familial adenomatous polyposis [39].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
What the sources say
- Not checked — no full text of the sourcecites [39] 39. Fodde, R., et al., A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proceedings of the National Academy of Sciences of the United States of America, 1994. 91(19): p. 8969-8973. source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“EMT is initiated when the cells lose adhesion and polarization while acquiring migratory properties as part of its interaction with other cells in a tumor [47].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
What the sources say
- Not checked — no full text of the sourcecites [47] 47. Thiery, J.P., et al., Epithelial-Mesenchymal Transitions in Development and Disease. Cell, 2009. 139(5): p. 871-890. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This can be explained by how the regional differences in a tumor arising from chemical and biological aspects of the niche will result in changes in the physical aspect of the niche.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Most current reviews either focus on specific fields such as cell migration and 3D cell culture or highlight the biological applications of in vitro tumor models [14][15][16], with limited emphasis on their contribution to anti-cancer drug screening and development.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 1. Introduction
What the sources say
- Not matchedcites [14][15][16]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Not matched
In the paper
“On a macroscopic level, the solid tumor microenvironment is very similar to that of an organ, where it comprises specialized cells being sustained by blood vessels, with each performing a different role in a tumor [17].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
What the sources say
- Not checked — no full text of the sourcecites [17] 17. Balkwill, F.R., M. Capasso, and T. Hagemann, The tumor microenvironment at a glance. Journal of Cell Science, 2012. 125(23): p. 5591-5596. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Moreover, it is important to note that successful translation from animal models to clinical cancer trials only stand at 8% [45].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
What the sources say
- Not matchedcites [45] 45. Mak, I.W.Y., N. Evaniew, and M. Ghert, Lost in translation: animal models and clinical trials in cancer treatment. American Journal of Translational Research, 2014. 6(2): p. 114-118.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Not matched
In the paper
“For instance, various collagens, including collagen I, II, III, V, and IX, have increased deposition rates during tumor formation [23][24][25].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
What the sources say
- Not matchedcites [23][24][25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Not matched
In the paper
“Studies conducted in recent years have demonstrated that the same tumor oncogenes and suppressor genes contribute to the development of cancer in humans and dogs [43].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
What the sources say
- Not checked — no full text of the sourcecites [43] 43. Paoloni, M. and C. Khanna, Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer, 2008. 8(2): p. 147-156. source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“There is much value in doing so because the tumor heterogeneity confers unique advantages for the tumor, such as an inherent resistance to therapy [10,11].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [10] 10. Holohan, C., et al., Cancer drug resistance: An evolving paradigm. Nature Reviews Cancer, 2013. 13(10). source
- Not checked — no full text of the sourcecites [11] 11. Trédan, O., et al., Drug resistance and the solid tumor microenvironment. Journal of the National Cancer Institute, 2007. 99(19): p. 1441-1454. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For instance, leaky blood vessels developed in a tumor will give rise to different sub-populations of cancer cells within a tumor as different hypoxic and pressure differences will be created in the niche (Figure 2).”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This implies that once the tumor explant has been used in an experiment, it may almost be impossible to obtain another explant with the same features to test the repeatability of the results.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“However, in the ECM of a tumor niche, changes in the amount, composition or topography of the ECM can lead to changes in the properties of the ECM itself.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“This increased expression of HIF-1 has also been demonstrated to drive angiogenesis by promoting the formation of vessels in the tumor microenvironment through the upregulation of the vascular endothelial growth factor (VEGF) protein [28].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
What the sources say
- Not checked — no full text of the sourcecites [28] 28. Lin, C., et al., Hypoxia induces HIF-1Œ± and VEGF expression in chondrosarcoma cells and chondrocytes. Journal of Orthopaedic Research, 2004. 22(6): p. 1175-1181. source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“As compared to the traditional transwell method, the monolayer design also has the added advantage of easily generating shear stress.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [106] 106. Ferrara, N. and R.S. Kerbel, Angiogenesis as a therapeutic target. Nature, 2005. 438(7070): p. 967-974. 122. Reymond, N., B.B. d'Agua, and A.J. Ridley, Crossing the endothelial barrier during metastasis. Nature Reviews Cancer, 2013. 13(12): p. 858-870. 123. Orimo, A., et al., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 2005. 121(3): p. 335-348. 124. Polanska, U.M. and A. Orimo, Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting mesenchymal cells. Journal of cellular phys source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“In this study, the migration speed of cancer cells in the ECM was shown to be slower than that in ECM/vessel interface and predefined matrix tracks.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [88] 88. Wong, A.D. and P.C. Searson, Live-cell imaging of invasion and intravasation in an artificial microvessel platform. Cancer research, 2014. 74(17): p. 4937-45. source
Strength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endothelial cells monolayer is the most direct approach to mimic blood vessel function in a microfluidic chip.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Many different material coatings, such as agarose, poly-HEMA and pluronic acid coatings have been proved to work well in forming viable cellular spheroids [67][68][69][70].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.2 Three-dimensional models
What the sources say
- Not matchedcites [67][68][69][70]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Not matched
In the paper
“Without recruiting new blood vessels, the size of a tumor is limited to a few millimeters in diameter [104].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [104] 104. Abadeer, N.S. and C.J. Murphy, Recent progress in cancer thermal therapy using gold nanoparticles. The Journal of Physical Chemistry C, 2016. 120(9): p. 4691-4716. 114. Liu, P.-F., et al., Far from resolved: Stromal cell-based iTRAQ research of muscle-invasive bladder cancer regarding heterogeneity. Oncology reports, 2014. 32(4): p. 1489-1496. 115. De Palma, M. and C.E. Lewis, Macrophage regulation of tumor responses to anticancer therapies. Cancer cell, 2013. 23(3): p. 277-286. 116. Hida, K., et al., Tumour endothelial cells acquire drug resistance in a tumour microenvironment. Journal o source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, a microfluidic tumor-on-a-chip can mimic the human body environment without the presence of foreign environmental factors.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4. Capturing essences of the tumor microenvironment -Complex microfluidics on-chip models
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The deviation in animal models caused by non-human genetic material is impossible to overcome.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, these models cannot predict tumor cell response accurately due to lack of a physiologically relevant microenvironment.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4. Capturing essences of the tumor microenvironment -Complex microfluidics on-chip models
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hence, there is a need for 3D models in order to obtain more information such as drug penetration or to aid in understanding the tumor niche better.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This may be attributed to how 2D layers are still spatially irrelevant given that actual tumors are 3D in nature.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“By implanting three such vessels in one chip and culturing HCCLM9 cancer cells in between, it was shown that the endothelial monolayer and pulse flow could significantly delay tumor migration [86].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [86] 86. Wang, X.-Y., et al., An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells. Lab on a Chip, 2015. 15(4): p. 1178-1187. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, the main advantage is that the 2D co-culture model offers a quick and simple method to mimic specific aspects of the tumor microenvironment.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Vasculature plays an essential role in the growth and metastasis of malignant tumors [103].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [103] 103. Sun, T., et al., Engineered nanoparticles for drug delivery in cancer therapy. Angewandte Chemie International Edition, 2014. 53(46): p. 12320-12364. 113. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Shear stress helps cells arrange themselves to establish the barrier function [106].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [106] 106. Ferrara, N. and R.S. Kerbel, Angiogenesis as a therapeutic target. Nature, 2005. 438(7070): p. 967-974. 122. Reymond, N., B.B. d'Agua, and A.J. Ridley, Crossing the endothelial barrier during metastasis. Nature Reviews Cancer, 2013. 13(12): p. 858-870. 123. Orimo, A., et al., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 2005. 121(3): p. 335-348. 124. Polanska, U.M. and A. Orimo, Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting mesenchymal cells. Journal of cellular phys source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The level of complexity increases as one progress from the use of endothelial cells monolayer to circular endothelial cells tube and to the functional vascular network.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Different from the previous two types of devices where the artificial blood vessel is formed on a well-defined surface, some devices prompt endothelial cells to sprout in the hydrogel to develop an irregular vascular network to mimic in vivo capillary vessel networks (Figure 3c).”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not matchedcites [94][95][96][97]107]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, the main drawback is that it is not able to mimic certain cell-cell interactions which cannot be transmitted through culture media such as the ECM interaction generated by fibroblasts and the immune response from WBCs.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Different from normal fibroblasts, cancer-associated fibroblasts proliferate faster, produce more extracellular matrix and secrete unique cytokine, which significantly enhances carcinogenesis [123, 124].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [123] 123. Somaweera, H., A. Ibraguimov, and D. Pappas, A review of chemical gradient systems for cell analysis. Anal Chim Acta, 2016. 907: p. 7-17. 194. source
- Not checked — no full text of the sourcecites [124] 124. Brennan, M.D., et al., Oxygen control with microfluidics. Lab Chip, 2014. 14(22): p. 4305-18. 195. Eccles, S.A., Targeting key steps in metastatic tumour progression. Current opinion in genetics & development, 2005. 15(1): p. 77-86. 196. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“This is, however, still different from the actual situation in the human body where shear stresses also exist inside the tumor [161].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Not checked — no full text of the sourcecites [161] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, mimicking cell-cell interactions is very necessary for the design of a comprehensive in vitro tumor model.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In addition, this shear stress can also prompt vascular angiogenesis against the direction of interstitial flow [152].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Not checked — no full text of the sourcecites [152] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As compared to a mixed co-culture, a separate co-culture can easily distinguish the different cell types cultured in the device without fluorescent staining.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Although this shear stress is very small when compared with the intravascular shear stress, it can still stimulate some oncogenic signaling pathways on cancer cells [150] as well as upregulate TGFβ and activate fibroblast contraction to stiffen the ECM [151].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Not checked — no full text of the sourcecites [150] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Its interplay with malignant cells is also key to cancer metastasis [122].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [122] 122. Diresta, G.R., et al., Cell proliferation of cultured human cancer cells are affected by the elevated tumor pressures that exist in vivo. Annals of biomedical engineering, 2005. 33(9): p. 1270-80. 190. Nathan, S.S., et al., Elevated Physiologic Tumor Pressure Promotes Proliferation and Chemosensitivity in Human Osteosarcoma. Clinical Cancer Research, 2005. 11(6): p. 2389. 191. Montel, F., et al., Isotropic stress reduces cell proliferation in tumor spheroids. New Journal of Physics, 2012. 14(5): p. 055008. 192. Tse, J.M., et al., Mechanical compression drives cancer cells toward invasive source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Elevated extracellular stresses have been observed in many tumors[170][171][172][173][174][175][176][177][178].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Not checked — no full text of the sourcecites [170] source
- Not checked — no full text of the sourcecites [171] source
- Not matchedcites [172]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [173]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [174]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [175]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [176]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [177] source
- Not matchedcites [178]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Chemical gradients play an important role in tumor cell invasion of metastatic cancer [195,196] as it significantly directs the migration and differentiation of tumor cells.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As such, it is hard to identify the effect of IFP on tumor alone.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although many current microfluidic devices have conducted research on the effect of IFP on tumor cells, they inadvertently mixed up an elevated IFP with fluid shear stress when a pressure-driven fluid flow is used (Figure 4c).”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Current microfluidic devices are capable of recapitulating in vivo chemical and oxygen gradient independently.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, the artificial microenvironment in a microfluidic chip is still a long way from the human body in terms of blood vessel architecture, cell lines used in co-culture models and functionality of mimicked elements.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, they are not able to generate oxygen gradient with spatial controls.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fully recapitulated tumor microenvironment in vitro is also impossible with current technologies.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“However, due to the impairment of blood and lymph vessels in a tumor, the IFP could rise up to more than 30mmHg at the center and drop drastically to the normal value at the periphery of a tumor[185].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Not matchedcites [185]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As compared to SS, the impact of interstitial pressure on tumors is better studied using microfluidics.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All the present approaches that mimic IFP have an associated shear stress due to the presence of significant fluid flow.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Spatial control of oxygen concentration, which allows for the study of cancer cells respond to different oxygen levels, is important for it can reproduce oxygen distribution seen in actual tumors.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cell sources used in most in vitro tumor models described are cell lines derived from human patients.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Besides, the current gold standard to validate proposed models still involves comparing the result with animal tests.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclear- Rests on an assumption: Animal tests are much more easily approved than clinical testing on human subjects.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For example, the efficacy of some anticancer drugs can be overestimated when these drugs are able to kill non-tumor cells in the tumor tissue because the drug efficacy is assessed based on the general cell viability of the whole tumor.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This is due to the difficulties in culturing primary tumor cells harvested from liquid biopsy or solid tumors and the heterogeneity in utilizing clinical samples.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This can be misleading in predicting tumor response in vitro.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Some microfluidic works have already demonstrated the feasibility of conducting patients' cell culture in microfluidic devices [133][134][135]163].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
What the sources say
- Not matchedcites [133][134][135]163]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Not matched
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“However, the relevance of using immortalized cells for biological studies is questionable with issues of mutation and contamination [219,220].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 55
- Probably not a substantial claim. 24
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Instead of simultaneously culturing various cell types in the same chamber, a separate coculture system grows each cell type in a separate chamber and all the cell-cell interaction is achieved by substance diffusion through the culture media between individual culture chambers [131, 139-148] (Figure 4b).”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [131] 131. Byrne, M.B., et al., Methods to study the tumor microenvironment under controlled oxygen conditions. Trends Biotechnol, 2014. 32(11): p. 556-563. 210. Chang, C.W., et al., A polydimethylsiloxane-polycarbonate hybrid microfluidic device capable of generating perpendicular chemical and oxygen gradients for cell culture studies. Lab Chip, 2014. 14(19): p. 3762-72. 211. Wang, Z., et al., Investigation into the hypoxia-dependent cytotoxicity of anticancer drugs under oxygen gradient in a microfluidic device. Microfluidics and Nanofluidics, 2015. 19(6): p. 1271-1279. 212. Lin, X., et al., Oxyge source
- Not checked — no full text of the sourcecites [139] source
- Partly supportedcites [140] sourceExperimental — accuracy not yet measured
The Anticipated Results section (page unavailable) describes different cell types cultured in separate channels and paracrine interactions across a hydrogel. But it also reports cells migrating through the gel to interact with other cells, so it does not support the claim that all interaction occurs by diffusion through culture media. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [141] source
- Disputedcites [142] sourceExperimental — accuracy not yet measured
The Introduction says the two cell types were initially cultured in distinct compartments, but the barrier was then removed to create a region for migration and interaction. Results and Discussion reports physical contact between the cells. Thus, the paper contradicts the claim that all interaction occurred through substances diffusing in media between separate chambers. Page numbers were not supplied in our copy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Supportedcites [143] source
The Materials and Methods section (Design and fabrication of the bionic invasion chip) places lung cancer cells and fibroblasts in separate chambers and describes their co-culture as non-contacting. It says fibroblast-secreted molecules can cross between chambers and describes culture-medium flow carrying secretions through the device. (LLM, conf=0.92)
- Partly supportedcites [144] sourceExperimental — accuracy not yet measured
The Experimental section describes culturing the two cell types in alternating gel channels, and the Conclusions say molecules can diffuse between adjacent channels. But the Conclusions also say cells can move across channel boundaries, and the Results report macrophages invading gels containing cancer cells. The paper therefore does not support the claim that all interaction occurs through diffusion in culture media. (LLM, conf=0.89)
- Supportedcites [145] source
Section 2.1 (page not provided) describes cells seeded into separate chambers without mixing. It states that diffusion ports allow soluble factors to pass between chambers while keeping the cell populations isolated, matching the cited description of indirect cell-cell interaction. (LLM, conf=0.91)
- Partly supportedcites [146] sourceExperimental — accuracy not yet measured
The device-fabrication and cell-observation passages describe four cell types grown in separate chambers, with channels allowing substances to diffuse between them. But the Cell morphological observations passage also reports a macrophage migrating through the matrigel toward bladder cancer cells, so the paper does not support the claim that all cell-cell interaction occurs by diffusion. (LLM, conf=0.88)
- Partly supportedcites [147] sourceExperimental — accuracy not yet measured
The Introduction (Figure 1 description) shows tumor cells and immune cells initially placed in separate chambers, with chemoattractant signals guiding immune cells through connecting microchannels. But it also describes immune cells migrating toward tumor cells; the Introduction says they must firmly bind their targets. Thus, the claim that all interaction occurs through diffusion between chambers is not supported. (LLM, conf=0.89)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Specifically, the tumor microenvironment has also been shown to induce tumor heterogeneity and promote the growth of a tumor itself [8,9].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 1. Introduction
What the sources say
- Partly supportedcites [8] 8. Joyce, J.A. and J.W. Pollard, Microenvironmental regulation of metastasis. Nature Reviews Cancer, 2009. 9(4). sourceExperimental — accuracy not yet measured
The passage beginning “Tumour–stroma interactions at the primary site” (page unavailable) says tumours exploit surrounding cells in processes that result in inappropriate growth. The passages do not say that the microenvironment induces tumour heterogeneity; describing tumours as complex mixtures of cell types does not establish that claim. (LLM, conf=0.86)
- Partly supportedcites [9] 9. Lalonde, E., et al., Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. The Lancet Oncology, 2014. 15(13): p. 1521-1532. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable in our copy) reports that preclinical work supports hypoxia generating genomic instability and selecting genetically unstable clones, which supports a role for the microenvironment in tumour heterogeneity. It links hypoxia to metastatic capacity, but does not say that the microenvironment promotes growth of the tumour itself. (LLM, conf=0.85)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As explants utilise similar techniques and equipment as those used in conventional cell culture work, this makes it easy for researchers to adopt tumor tissue explants in their research [36,37].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
What the sources say
- Not checked — no full text of the sourcecites [36] 36. Hegerfeldt, Y., et al., Collective Cell Movement in Primary Melanoma Explants. Cancer Research, 2002. 62(7): p. 2125-2130.
- Partly supportedcites [37] 37. Provenzano, P.P., et al., Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Medicine, 2006. 4(1): p. 38-38. sourceExperimental — accuracy not yet measured
The Methods section, “Tumor explants and collagen gel culture” (page unavailable), describes culturing tumor explants with culture dishes, DMEM, antibiotics, and serum, supporting overlap with conventional cell culture. It does not compare the overall techniques or equipment with conventional culture or say that researchers can easily adopt explant methods. (LLM, conf=0.82)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Major molecular targets such as PTEN, BRAC1 or p53 have demonstrated sequencing identities that are more similar to humans as compared to those from a mouse, thereby indicating that a more accurate model can potentially be established [34].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
What the sources say
- Partly supportedcites [34] 34. Cekanova, M. and K. Rathore, Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Design, Development and Therapy, 2014. 8: p. 1911-1911. sourceExperimental — accuracy not yet measured
The Companion animals section (page not available) says canine and feline cancer-related genes, including p53, are more similar to human genes than to mouse genes, and it names BRCA1 among homologous human and dog cancer-associated proteins. It supports the potential value of companion animals as cancer models, but the passages do not establish the specific comparison for PTEN or show that sequence similarity alone makes a model more accurate. (LLM, conf=0.84)
Strength:boosted· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For instance, a missense mutation in the p53 transcription factor, which can be held accountable for tumor initiation, development, and growth in more than half of solid tumor cancers [32].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
What the sources say
- Partly supportedcites [32] 32. Aylon, Y. and M. Oren, New plays in the p53 theater. Current Opinion in Genetics & Development, 2011. 21(1): p. 86-92. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says p53 is mutated in approximately 50% of human cancers and describes its role in tumor prevention. The section on tumor cell invasion (page unavailable) says mutant p53 can promote cancer progression and metastasis. Neither passage establishes that the mutations are specifically missense mutations, that the figure exceeds half, or that it applies specifically to solid tumors. (LLM, conf=0.88)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“As a result, solid tumors are inherently heterogeneous and structurally complex [18].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
What the sources say
- Supportedcites [18] 18. Chen, F., et al., New horizons in tumor microenvironment biology: challenges and opportunities. BMC Medicine, 2015. 13(1): p. 45-45. source
The Introduction describes tumors as three-dimensional structures involving diverse cells and discusses spatial and temporal heterogeneity. The Conclusions and future directions section explicitly calls the tumor microenvironment structurally complex, supporting the paraphrase about solid tumors. (LLM, conf=0.91)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Over the past two decades, many models have been created to mimic this microenvironment and various techniques involving small animal models or two-dimensional (2D) in vitro cancer models have been developed for drug testing and screening [34,35].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
What the sources say
- Partly supportedcites [34] 34. Cekanova, M. and K. Rathore, Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Design, Development and Therapy, 2014. 8: p. 1911-1911. sourceExperimental — accuracy not yet measured
The Introduction describes three-dimensional and coculture models that mimic tumor–matrix interactions, alongside two-dimensional cancer cell models. The rodent xenograft section describes animal models used to test and develop cancer therapies. The copy does not establish the claimed two-decade timeframe, and it says two-dimensional cultures are isolated from the tumor microenvironment rather than mimicking it. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [35] 35. Ellem, S.J., E.M. De-Juan-Pardo, and G.P. Risbridger, In vitro modeling of the prostate cancer microenvironment. Advanced Drug Delivery Reviews, 2014. 79: p. 214-221. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Briefly, the p53 protein acts as a tumor suppressor as it induces apoptosis when cellular mutations occur and initiate DNA repairs in healthy cells [32].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
What the sources say
- Partly supportedcites [32] 32. Aylon, Y. and M. Oren, New plays in the p53 theater. Current Opinion in Genetics & Development, 2011. 21(1): p. 86-92. sourceExperimental — accuracy not yet measured
The Introduction says that stress activates p53, which facilitates DNA repair and can instigate apoptosis; it also describes p53’s role in tumor prevention. It does not specifically say that mutations trigger apoptosis or distinguish DNA repair in healthy cells from repair in other cells. (LLM, conf=0.82)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In that approach, the hydrogel not only works as a scaffold for the growth of endothelial cells monolayer but also serves a function of mimicking the ECM for tumor spheroid formation.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Partly supportedcites [84] 84. Bai, J., et al., Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment. Oncotarget, 2015. 6(34): p. 36603. sourceExperimental — accuracy not yet measured
The Materials and Methods section says endothelial cells formed a monolayer on the collagen gel surface and that tumor aggregates were embedded in a second collagen gel region. But the Results say the aggregates were formed in non-adhesive microwells before being cultured in the device; the paper does not support saying the hydrogel was used for tumor spheroid formation. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Partly supportedcites [85] 85. Riahi, R., et al., A microfluidic model for organ-specific extravasation of circulating tumor cells. Biomicrofluidics, 2014. 8(2): p. 024103. sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable) report that a Matrigel coating helped form a confluent endothelial monolayer. The Materials and Methods describe hydrogel used for chemokine delivery, but the paper does not describe using it to mimic ECM for tumor spheroid formation; it studies circulating tumor-cell extravasation instead. (LLM, conf=0.88)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For instance, 2D models cannot be used in the testing of drug efficacy as previous studies have shown that the efficacy still varies quite substantially between in vivo as compared to 2D monoculture [52,53].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
What the sources say
- Not checked — no full text of the sourcecites [52] 52. Horvath, P., et al., Screening out irrelevant cell-based models of disease. Nature Reviews Drug Discovery, 2016. 15(11): p. 751-769. source
- Partly supportedcites [53] 53. Imamura, Y., et al., Comparison of 2D-and 3D-culture models as drug-testing platforms in breast cancer. Oncology reports, 2015. 33(4): p. 1837-1843. sourceExperimental — accuracy not yet measured
The Introduction and Discussion say 2D cultures do not precisely simulate tumors in vivo and may overestimate anticancer activity. But the paper does not say 2D models cannot be used for drug-efficacy testing, and its Results compare 2D with 3D cultures rather than directly measuring a substantial efficacy difference between 2D cultures and in vivo tumors. (LLM, conf=0.86)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Suspension culture generally has high throughput but lack the ability to control the size and uniformity of the spheroids formed [64,65].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.2 Three-dimensional models
What the sources say
- Not checked — no full text of the sourcecites [64] 64. Barrila, J., et al., Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nature Reviews Microbiology, 2010. 8(11): p. 791-801. source
- Partly supportedcites [65] 65. Sant, S. and P.A. Johnston, The production of 3D tumor spheroids for cancer drug discovery. Drug Discovery Today: Technologies, 2017. sourceExperimental — accuracy not yet measured
The ‘Anchorage-independent tumor spheroids’ section says many methods produce aggregates with widely varying sizes and morphologies, supporting the uniformity concern. It does not support the claim that suspension culture generally has high throughput: it says some methods are labor-intensive and have been used only for small pilot screens. The ‘Ultra-low attachment microplates’ section also describes a method that is suitable for high-throughput screening and produces uniform-sized spheroids. (LLM, conf=0.88)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Conventional in vitro culture methods could also generate three-dimensional tumor structure which is more physiologically relevant than 2D models and more cost-efficient than animal models [57].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.2 Three-dimensional models
What the sources say
- Partly supportedcites [57] 57. Asghar, W., et al., Engineering cancer microenvironments for in vitro 3-D tumor models. Materials Today, 2015. 18(10): p. 539-553. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says 3-D in vitro models can better recapitulate the natural tumor microenvironment and are relatively inexpensive compared with conventional methods, including animal models. But it describes 3-D models as an alternative to conventional 2-D in vitro culture, not as structures generated by conventional culture methods. (LLM, conf=0.88)
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It has high reliability and reproducibility but fluid volume is limited and the method is not good for long-term culture due to difficulty in refreshing the culture medium [58,75].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.2 Three-dimensional models
What the sources say
- Partly supportedcites [58] 58. Mehta, G., et al., Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. Journal of Controlled Release, 2012. 164(2): p. 192-204. sourceExperimental — accuracy not yet measured
In ‘Challenge 1: Forming and maintaining spheroids of uniform size’ (page not provided), the paper says conventional hanging drops allow defined spheroid size but that changing medium is time-consuming, supporting the culture-maintenance concern. It describes 15–20 μl drops in a particular plate, not a general fluid-volume limit, and does not establish high reliability for hanging-drop methods generally. It also reports that an improved hanging-drop plate enables long-term culture, so the limitation needs to be qualified as applying to conventional methods. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [75] 75. Breslin, S. and L. O'Driscoll, Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today, 2013. 18(5-6): p. 240-9. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“It was found that fluid shear stress could prompt ovarian cancer cell dissemination, enrich cancer stem cell population as well as enhance tumor's chemoresistance to anti-cancer drugs.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Supportedcites [156] source
The Discussion says peritoneal ascitic flow contributes to ovarian cancer dissemination and may facilitate CSC enrichment. The Abstract reports increased CSC markers and resistance to cisplatin and paclitaxel in ovarian cancer cells grown under fluid shear stress compared with static conditions. (LLM, conf=0.92)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Almost all current microfluidic devices incorporating fluid flow can generate a shear stress with physiologically relevant value and can demonstrate the impact of shear stress in cultured tumor cells in vitro [157-160].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Partly supportedcites [157] sourceExperimental — accuracy not yet measured
The Introduction (page not available) says interstitial flow can exert shear stress and influence cell behavior, and the Discussion describes a microfluidic device that controls interstitial flow. But the paper does not establish that almost all flow-based microfluidic devices generate physiologically relevant shear stress. Its demonstrated application was vascular network formation using endothelial and stromal cells, not the effect of shear stress on cultured tumor cells. (LLM, conf=0.86)
- Partly supportedcites [158] sourceExperimental — accuracy not yet measured
The Introduction describes this paper’s microfluidic device operating at a physiological venular shear stress of approximately 1 dyn cm−2. The Discussion reports its use to study metastatic colon carcinoma cell adhesion under shear flow. This supports the device as an example, but the paper does not establish that almost all current microfluidic devices have these capabilities. (LLM, conf=0.85)
- Partly supportedcites [159] sourceExperimental — accuracy not yet measured
The Results and Discussions sections (pages not provided) describe one microfluidic platform that produces flow-induced shear stress and shows changes in cultured esophageal cancer cells. The paper does not establish that almost all current flow-based microfluidic devices do so, or that their shear-stress values are physiologically relevant. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [160] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition to increasing drug resistance, a high SS could influence tumor cells' gene expression, comprise immune cells ability to kill cancerous cells or even turn macrophages to tumorfriendly cells, thereby enhancing the metastatic potential of cancer cells [180-184].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Not checked — no full text of the sourcecites [180] source
- Not checked — no full text of the sourcecites [181] source
- Partly supportedcites [182] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [183] source
- Partly supportedcites [184] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The pressure gradient was found out to induce cell adhesion activation, cell polarization along flow direction and migration towards regions with higher pressures.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Supportedcites [168] source
The paper describes a microfluidic platform in which a pressure-driven interstitial flow produces adhesion activation and upstream cell polarization (p. 2). The Discussion (p. 5) reports migration upstream, toward maximum adhesion tension; upstream is toward the higher-pressure side of the flow. (LLM, conf=0.88)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Most of them control the oxygen levels in culture chambers and can be categorized into three groups; introducing oxygen scavenging chemicals [210, 211], gas supply channels adjacent to the cell chamber [212] and oxygen impermeable materials [213, 214].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
What the sources say
- Not checked — no full text of the sourcecites [210] source
- Not checked — no full text of the sourcecites [211] source
- Supportedcites [212] source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [213] source
- Not matchedcites [214]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Abnormal SS is developed by the unregulated growth of tumorigenic cells and is transmitted by the extracellular matrix[179].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Supportedcites [179] source
The Discussion (page not supplied) explains that cancer cells proliferate uncontrollably and that their expansion generates solid stress. It also says the resulting force is stored in deformations of other cells and the extracellular matrix, which links to cells. (LLM, conf=0.90)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Hypoxic environment, on the other hand, is known to reduce cytotoxicity of many anticancer drugs, affect angiogenesis, promote metastasis and alter the metabolic activity of cancer cells [183,197].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
What the sources say
- Not checked — no full text of the sourcecites [183] source
- Supportedcites [197] source
The “Radiation and drug resistance” section says hypoxia can make tumor cells resistant to chemotherapy and describes mechanisms that reduce treatment effectiveness. The “Tumor microenvironment” section links hypoxia to new blood-vessel formation, the “Metastasis” section links it to increased spread, and the Conclusion states that hypoxia regulates metabolism. Together, these passages support the cited sentence’s broad paraphrase. (LLM, conf=0.92)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“By using co-culture models, it was found that cancer-associated fibroblasts may promote cancer cell invasion [143].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
What the sources say
- Supportedcites [143] source
The Results section reports that secretions from a co-culture in which fibroblasts became cancer-associated fibroblasts induced invasion of A549 and SPCA-1 lung cancer cells; invasion was not observed with ordinary fibroblast secretions. This supports the citing sentence’s hedged claim based on a co-culture model. Page numbers were not supplied. (LLM, conf=0.93)
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Since different sub-populations of a tumor can respond differently to therapy, this makes it difficult for clinicians to treat cancer effectively.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 1. Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Moreover, VEGF is expressed in varying quantities within a tumor.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It is important to note here that the upregulation of VEGF is only one of the pathways through which angiogenesis is induced.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Due to this difference, the cells in a tumor respond differently to these cues and in the process, creates tumor heterogeneity.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Indeed, this has made mouse models highly popular with researchers (65% of 949 oncology papers published in 2016 utilized a mouse tumor model [42]).”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
What the sources say
- Not checked — no full text of the sourcecites [42] 42. Gengenbacher, N., M. Singhal, and H.G. Augustin, Preclinical mouse solid tumour models. Nature Publishing Group, 2017. 17(12): p. 751-765. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It is for these reasons that researchers seek to build tumor models using methods which have a higher throughput and less batch-to-batch variation than those mentioned above.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Moreover, since the tumor explant is derived from the original patient sample, the tumor architecture is largely preserved, making this a representative model.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Alternatively, through the expression of oncogenes such as such Ras or Myc inside tumor cells, angiogenesis can also be induced in a tumor.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“This discrepancy may be attributed to a variety of reasons ranging from the tangible, such as the lack of a standardized protocol for animal testing unlike in human trials [42], to the intangible such as how stress experienced in mice has been demonstrated to have a substantial impact on the experimental results [46].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
What the sources say
- Not checked — no full text of the sourcecites [42] 42. Gengenbacher, N., M. Singhal, and H.G. Augustin, Preclinical mouse solid tumour models. Nature Publishing Group, 2017. 17(12): p. 751-765. source
- Not checked — no full text of the sourcecites [46] 46. Chesler, E.J., et al., Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive. Neuroscience & Biobehavioral Reviews, 2002. 26(8): p. 907-923. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“For instance, cancer metastasis which is the leading cause of death in cancer patients occurs through a series of mechanisms (most prominently the epithelial to mesenchymal transition [EMT]).”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.1 Two-dimensional models
What the sources say
- Not checked — no full text of the sourcecites [47] 47. Thiery, J.P., et al., Epithelial-Mesenchymal Transitions in Development and Disease. Cell, 2009. 139(5): p. 871-890. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Through the development of an in vitro model which can accurately represent the in vivo conditions of the tumor microenvironment, this would help not only researchers develop better drugs but could also pave the way for clinicians to personalize cancer therapy for individuals.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 1. Introduction
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As the expression of VEGF promotes neo-vascularization in tumors, this results in a network of blood vessels within a tumor which cannot be replicated or predicted easily, thereby making the tumor microenvironment highly complex.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“However, for all the benefits that an animal-based model confers, they still have underlying ethical issues and have very strict regulations regarding the use of them which restricts their use to only very specific purposes such as in a drug test.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“However, as mice can tolerate higher drug concentrations than human patients, questions about their effectiveness in using them for drug tests will remain even if a representative 3D model is to be created.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3. Non-microfluidic tumor models
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, this heterogeneity will manifest both chemically and biologically which will then give rise to genetic and phenotypic variations seen in tumors.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 1. Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“For instance, apart from the malignant cells, the tumor microenvironment also includes several different immune cell types, cells from blood vessels (pericytes and adipocytes) and fibroblasts, each interacting and exhibiting dependencies on each other.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By doing so, cell growth is enhanced by stiffening and cell-cell junction integrity is compromised, impeding lumen formation.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 2. Tumor microenvironment
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“However, scaffold base culture also has drawbacks of batch variance, limited throughput, non-uniform spheroid size and distribution [63].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.2 Three-dimensional models
What the sources say
- Not checked — no full text of the sourcecites [63] 63. Breslin, S. and L. O'Driscoll, Three-dimensional cell culture: the missing link in drug discovery. Drug discovery today, 2013. 18(5): p. 240-249. source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Many different materials such as chitosan-alginate, collagen, Matrigel and Puramatrix hydrogel, were capable of forming such a scaffold structure [77][78][79][80][81].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.2 Three-dimensional models
What the sources say
- Not matchedcites [77][78][79][80][81]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“An arguable advantage of this approach is that the scaffold could mimic ECM and better recapitulate the in vivo microenvironment.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.2 Three-dimensional models
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It also has the advantage of being cost-effective while maintaining a high throughput.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4. Capturing essences of the tumor microenvironment -Complex microfluidics on-chip models
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“Although fabrication of the device is quite tedious, the artificial blood vessels generated by this method have relatively high mechanical strength and look like real blood vessels [86].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [86] 86. Wang, X.-Y., et al., An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells. Lab on a Chip, 2015. 15(4): p. 1178-1187. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“This method can effectively build a circular endothelial cell tube in a microfluidic device, but the co-cultured cancer cells must be fixed in the hydrogel first before construction of the endothelial cellular tube can begin.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not matchedcites [87][88][89][90][91]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Not matched
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“On the other hand, although animal models have been used to recapitulate the human body environment, it is a time-consuming and expensive approach.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4. Capturing essences of the tumor microenvironment -Complex microfluidics on-chip models
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although it can be very challenging to fully regenerate the in vivo microenvironment in a microfluidic system, researchers have been able to capture some key features in the tumor to recapitulate the process of tumor growth and use it to better predict drug response.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4. Capturing essences of the tumor microenvironment -Complex microfluidics on-chip models
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The more complicated devices are, the closer a representative of in vivo conditions can be achieved albeit with a lower throughput and becoming harder to operate.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“The blood vessels developed in this type of devices are cross-linked and perfusable, closely recapitulating the in vivo blood flow conditions [94][95][96][97]107].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not matchedcites [94][95][96][97]107]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As such, the development of a more comprehensive microfluidic tumor model with better-mimicked vasculature will allow in vitro fast screening of such treatment and greatly contribute to the development of anti-cancer drugs.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Although the size of spheroids generated using this method varies in a large range, this problem can be overcome by using microarrays instead [66].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 3.2 Three-dimensional models
What the sources say
- Not checked — no full text of the sourcecites [66] 66. Fennema, E., et al., Spheroid culture as a tool for creating 3D complex tissues. Trends in biotechnology, 2013. 31(2): p. 108-115. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“This monolayer approach is very effective in applications where cylindrical vessel geometry of blood vessels is not very essential to the study, such as in the testing of drugs which prevent cancer cell migration because this method is high throughput and simple to fabricate [106].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [106] 106. Ferrara, N. and R.S. Kerbel, Angiogenesis as a therapeutic target. Nature, 2005. 438(7070): p. 967-974. 122. Reymond, N., B.B. d'Agua, and A.J. Ridley, Crossing the endothelial barrier during metastasis. Nature Reviews Cancer, 2013. 13(12): p. 858-870. 123. Orimo, A., et al., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 2005. 121(3): p. 335-348. 124. Polanska, U.M. and A. Orimo, Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting mesenchymal cells. Journal of cellular phys source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Endothelial cells are one of the major components of blood vessels and play an important role in tumor angiogenesis [121].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [121] 121. Boucher, Y., L.T. Baxter, and R.K. Jain, Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer research, 1990. 50(15): p. 4478-4484. 186. Chauhan, V.P., et al., Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nature nanotechnology, 2012. 7(6): p. 383-388. 187. Jain, R.K., R.T. Tong, and L.L. Munn, Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer research,
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Although this shear stress is very small when compared with the intravascular shear stress, it can still stimulate some oncogenic signaling pathways on cancer cells [150] as well as upregulate TGFβ and activate fibroblast contraction to stiffen the ECM [151].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Not checked — no full text of the sourcecites [151] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In current microfluidic models culturing three-dimensional tumors, fluid only flows around tumor spheroids and the quantified shear stress value is the shear stress on the outer surface of the tumor.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Different from normal fibroblasts, cancer-associated fibroblasts proliferate faster, produce more extracellular matrix and secrete unique cytokine, which significantly enhances carcinogenesis [123, 124].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
What the sources say
- Not checked — no full text of the sourcecites [123] 123. Somaweera, H., A. Ibraguimov, and D. Pappas, A review of chemical gradient systems for cell analysis. Anal Chim Acta, 2016. 907: p. 7-17. 194. source
- Not checked — no full text of the sourcecites [124] 124. Brennan, M.D., et al., Oxygen control with microfluidics. Lab Chip, 2014. 14(22): p. 4305-18. 195. Eccles, S.A., Targeting key steps in metastatic tumour progression. Current opinion in genetics & development, 2005. 15(1): p. 77-86. 196. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“It enhances tumor cell proliferation and builds up a transport barrier to drug delivery, greatly lowering the efficacy of anticancer drugs and therapies.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
What the sources say
- Not checked — no full text of the sourcecites [170] source
- Not checked — no full text of the sourcecites [171] source
- Not matchedcites [172]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [173]
- Not checked — no full text of the sourcecites [174]
- Not checked — no full text of the sourcecites [175]
- Not checked — no full text of the sourcecites [176]
- Not checked — no full text of the sourcecites [177] source
- Not matchedcites [178]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This dynamic response was regulated by the β-catenin dependent Wnt signaling pathway [202].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
What the sources say
- Not checked — no full text of the sourcecites [202] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, mimicking static fluid pressure is key to understanding the role of IFP in drug resistance of tumor and whether it is necessary to be recapitulated in an in vitro drug screening platform (Figure 4d).”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.1 Vasculature
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“A hypoxic environment can be easily incorporated into most existing systems by using a hypoxic incubator or a hypoxic workstation [194].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
What the sources say
- Not checked — no full text of the sourcecites [194] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Many recent microfluidic devices were utilized to generate chemical or oxygen gradient in cancer research because chemical and oxygen concentrations have also been shown to greatly affect cancer progression and therapeutic efficacy [193,194].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 4.5 Chemical and oxygen gradient
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As discussed, current microfluidic tumor models have achieved much in showing the significance of incorporating the vascular system, co-culture with physiologically relevant cell types and mimicking elevated interstitial fluid pressures as well as shear stresses.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, the key to developing a successful microfluidic tumor model is to select and incorporate essential features which can facilitate better drug response prediction depending on the application.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While large artificial blood vessels generated by planar or circular channels can reproduce a physiologically relevant multilayer structure, which comprises of mainly endothelial cells, vascular smooth muscle, and connective tissue, these vessels are often too big to be implanted in a vascularized tumor.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“On the other hand, although the artificial vascular network has similar dimensions to normal capillaries and allows coculture of multiple cell types, building a vascularized artificial tumor remains a big challenge.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“For example, current approaches with an elevated pressure chamber do not have a blood vessel component and the magnitude of pressure is less than 10% of actual IPF in vivo [166][167][168][169].”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
What the sources say
- Not matchedcites [166][167][168][169]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Some elements among the in vivo microenvironments such as IFP and shear stress have been mimicked in microfluidic devices, but their full functionality has not been reproduced yet.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, nutrients and drugs are not delivered through the vascular network in these studies, which compromise the prediction of drug response in these models.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 5. Future directions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It is inevitable that the future generation of in vitro tumor models will need to use primary human cells with integrated into vivo conditions in order to generate predictions which are physiologically more relevant.”
§ Functionalizing the Tumor Microenvironment with Microfluidics for Anticancer Drug Development > 6. Conclusion
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence.
The paper relies on this without support.
The deviation in animal models caused by non-human genetic material is impossible to overcome.
“In addition, the deviation in animal models caused by non-human genetic material seems impossible to be overcome.”
The paper relies on this without support.
Many different non-neoplastic cells exist in the tumor microenvironment and interact with tumor cells.
“Many different non-neoplastic cells exist in the tumor microenvironment and interact with tumor cells.”
The paper relies on this without support.
No more than 4 fluorescent dyes are usually used simultaneously on a single device due to cross-talking between fluorescent signals.
“However, due to the concern of cross-talking between fluorescent signals, no more than 4 fluorescent dyes are usually used simultaneously on a single device.”
The paper relies on this without support.
IFP is usually close to zero in normal tissue.
“It is usually close to zero in normal tissue.”
The paper relies on this without support.
There is usually a hypoxic core of solid tumors due to the abnormal vascular network and high cell density.
“There is usually a hypoxic core of solid tumors due to the abnormal vascular network and high cell density.”
The paper relies on this without support.
Commercially available cell lines are commonly used in co-culture models.
“Commercially available cell lines are commonly used in co-culture models.”
The paper relies on this without support.
Animal tests are much more easily approved than clinical testing on human subjects.
“This is primarily because animal tests are much more easily approved than clinical testing on human subjects.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By incorporating organoids into a micro fl uidic device, organoids-ona-chip inherit the combined bene fi ts of both micro fl uidics and 3D organoid models, thus providing a unique way to study tumor -stroma interactions and their systemic effects [69,74 -76].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These tumor-on-chip systems are expected to increase the effective identification of new and better cancer therapies while minimizing non-specific toxicity [13,14,15,16,17].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given their tumor‐like properties, tumor spheroids have been used as routine drug screening models to reduce drug development costs and unnecessary animal experiments.[ 49 ]”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Tumor-on-chip models based on these organ-on-chip systems can recreate human tumor microenvironments and now hold great promise as a new resource for cost-effective and higher-throughput screening of anticancer drugs [13,14,15,16,17] and powerful enablers of precision medicine [18].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“Tumor-on-chip models based on these organ-on-chip systems can recreate human tumor microenvironments and now hold great promise as a new resource for cost-effective and higher-throughput screening of anticancer drugs [13,14,15,16,17] and powerful enablers of precision medicine [18].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Cancer is ranked both first and second as a cause of death
MinorThe abstract calls cancer the leading cause of death worldwide, while the introduction calls it the second leading cause globally.
“Cancer is the leading cause of death worldwide.”
“Cancer is the second leading cause of death in the world, in both developed countries and less developed countries [1].”
Conflicting descriptions of where tumor hypoxia occurs
MinorOne section singles out cells near the tumor periphery as becoming hypoxic because they lack access to a blood vessel; a later section instead describes the tumor core as the usual hypoxic region.
“some cells especially those near the periphery of a tumor do not have access to a blood vessel.As a result, these cells enter a state of hypoxia”
“There is usually a hypoxic core of solid tumors due to the abnormal vascular network and high cell density.”
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,338
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Flagged first, then by citations
Research works printed but not linked: 17
- WHO , Cancer , WHO , 2017
- Hegerfeldt, 2002, Cancer Res., 62, 2125
- N. Gengenbacher , M.Singhal and H. G.Augustin , Preclinical mouse solid tumour models , Nature Publishing Group , 2017 , vol. 17 12 , pp. 751–765
- Mak, 2014, Am. J. Transl. Res., 6, 114
- Breslin, 2013, Drug Discovery Today, 18, 240, 10.1016/j.drudis.2012.10.003 · DOI · Paper page
- Ahn, 2017, IEEE Trans. Nanotechnol., 1
- Khoo, 2016, Sci. Adv., 2, e1600274, 10.1126/sciadv.1600274 · DOI · Paper page
- Trietsch, 2013, Lab Chip, 13, 3548, 10.1039/c3lc50210d · DOI · Paper page
- Less, 1992, Cancer Res., 52, 6371
- Curti, 1993, Cancer Res., 53, 2204
- Gutmann, 1992, Cancer Res., 52, 1993
- Griffon-Etienne, 1999, Cancer Res., 59, 3776
- Leu, 2000, Cancer Res., 60, 4324
- Boucher, 1991, Cancer Res., 51, 6691
- Boucher, 1990, Cancer Res., 50, 4478
- Weigelt, 2005, Nat. Rev. Cancer, 5, 591, 10.1038/nrc1670 · DOI · Paper page
- Wang, 2015, Lab Chip, 15, 1445, 10.1039/C4LC01451K · DOI · Paper page
Cited by
Sorted by citations
A guide to the organ-on-a-chip
Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116
3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405
Role of Nanoparticle Mechanical Properties in Cancer Drug Delivery
Hui, Y., Yi, X., Hou, F., Wibowo, D., Zhang, F., Zhao, D., Gao, H., & Zhao, C. (2019) · ACS Nano · doi:10.1021/acsnano.9b03924 · Cited by 398
“62,63 Interaction with Cancer Cells.”
Tumor microenvironment: barrier or opportunity towards effective cancer therapy
Tiwari, A., Trivedi, R., & Lin, S. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00866-3 · Cited by 399
“These models can be used to study tumor-stroma interactions and their systemic effects simultaneously [27, 242, 243].”
BackgroundEmerging roles of ECM remodeling processes in cancer
Mohan, V., Das, A., & Sagi, I. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.004 · Cited by 343
Metadata
- Authors
- Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J.
- Affiliations
- National University of Singapore (SG)
- Singapore-MIT Alliance for Research and Technology (SG)
- Corresponding author
- Lim, Chwee Teck
- Khoo, Bee Luan
- Han, Jongyoon
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2019
- Volume
- 19
- Issue
- 3
- Pages
- 369-386
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2907333863
- Cited by
- 227
- References
- 217
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 24 · 2023: 36 · 2022: 45 · 2021: 35 · 2020: 36 · 2019: 22
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- Funders
- Mechanobiology Institute, Singapore
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor microenvironment, microfluidic tumor model, anticancer drug discovery, in vitro drug testing, 3D tumor models, 2D cell culture, animal models, personalized medicine
- MeSH terms
- Animals, Antineoplastic Agents, Drug Screening Assays, Antitumor, Humans, Lab-On-A-Chip Devices, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review